Simple compound could provide first new therapy for myeloid leukemia in four decades
Researchers at Massachusetts General Hospital (MGH) and the Harvard Stem Cell Institute (HSCI) have identified a drug compound that arrests in mice the progression of acute myeloid leukemia (AML), a bone marrow cancer that ...
Sep 16, 2016
0
76